|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US5919816A
(en)
*
|
1994-11-14 |
1999-07-06 |
Bionumerik Pharmaceuticals, Inc. |
Formulations and methods of reducing toxicity of antineoplastic agents
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20020155999A1
(en)
*
|
1998-04-30 |
2002-10-24 |
Han In Suk |
Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer
|
|
US7314637B1
(en)
|
1999-06-29 |
2008-01-01 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
|
US6075053A
(en)
*
|
1999-02-09 |
2000-06-13 |
Bionumerik Pharmaceuticals, Inc. |
Method of reducing or reversing neuropathy
|
|
US6197831B1
(en)
*
|
1999-02-09 |
2001-03-06 |
Bionumerik Pharmaceuticals, Inc. |
Method of treating septic shock
|
|
US6395481B1
(en)
*
|
1999-02-16 |
2002-05-28 |
Arch Development Corp. |
Methods for detection of promoter polymorphism in a UGT gene promoter
|
|
US20030036513A1
(en)
*
|
1999-02-16 |
2003-02-20 |
Yurkow Edward J. |
Method for treating cancer
|
|
GB9904386D0
(en)
*
|
1999-02-25 |
1999-04-21 |
Pharmacia & Upjohn Spa |
Antitumour synergistic composition
|
|
US6664288B1
(en)
*
|
1999-04-14 |
2003-12-16 |
Dana Farber Cancer Institute, Inc. |
Method and composition for the treatment of cancer
|
|
US20050222246A1
(en)
*
|
1999-04-14 |
2005-10-06 |
Li Chiang J |
Beta-lapachone is a broad spectrum anti-cancer agent
|
|
US20050192360A1
(en)
*
|
1999-04-14 |
2005-09-01 |
Li Chiang J. |
Method of treatment of pancreatic cancer
|
|
CA2369740A1
(en)
*
|
1999-04-22 |
2000-11-02 |
American Biosciences, Inc. |
Long term administration of pharmacologically active agents
|
|
MY164077A
(en)
*
|
1999-05-13 |
2017-11-30 |
Pharma Mar Sa |
Compositions and uses of et743 for treating cancer
|
|
US6034126A
(en)
*
|
1999-05-24 |
2000-03-07 |
Bionumerik Pharmaceuticals, Inc. |
Method for treating glycol poisoning
|
|
GB9916882D0
(en)
*
|
1999-07-19 |
1999-09-22 |
Pharmacia & Upjohn Spa |
Antitumor synergistic composition
|
|
US6294546B1
(en)
*
|
1999-08-30 |
2001-09-25 |
The Broad Of Trustees Of The Leland Stanford Junior University |
Uses of diterpenoid triepoxides as an anti-proliferative agent
|
|
WO2001024763A2
(en)
|
1999-10-01 |
2001-04-12 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
AU1612301A
(en)
*
|
1999-11-15 |
2001-05-30 |
Parker Hughes Institute |
Phorboxazole derivatives for treating cancer
|
|
US6890946B2
(en)
*
|
1999-12-23 |
2005-05-10 |
Indiana University Research And Technology Corporation |
Use of parthenolide to inhibit cancer
|
|
AU2000239101A1
(en)
*
|
2000-03-22 |
2001-10-03 |
Neopharm, Inc. |
A method of administering liposomal encapsulated taxane
|
|
GB0011927D0
(en)
*
|
2000-05-17 |
2000-07-05 |
Inst Biomar Sa |
New use of citreamicins
|
|
GB0011903D0
(en)
*
|
2000-05-18 |
2000-07-05 |
Astrazeneca Ab |
Combination chemotherapy
|
|
US20050197405A1
(en)
*
|
2000-11-07 |
2005-09-08 |
Li Chiang J. |
Treatment of hematologic tumors and cancers with beta-lapachone, a broad spectrum anti-cancer agent
|
|
EP1355634B8
(en)
|
2000-11-09 |
2009-03-04 |
Neopharm, Inc. |
Sn-38 lipid complexes and methods of use
|
|
JP2004523518A
(ja)
*
|
2001-01-19 |
2004-08-05 |
バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド |
より効能が大きく副作用の少ない癌治療方法
|
|
US6620843B2
(en)
*
|
2001-01-19 |
2003-09-16 |
Pharmagenesis |
Anticancer treatment using triptolide prodrugs
|
|
US20030149096A1
(en)
*
|
2001-02-05 |
2003-08-07 |
Pezzuto John M. |
Cancer chemopreventative compounds and compositions and methods of treating cancers
|
|
WO2002076459A1
(en)
*
|
2001-03-06 |
2002-10-03 |
Bristol-Myers Squibb Company |
Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
|
|
SI1372650T1
(sl)
*
|
2001-03-19 |
2009-04-30 |
Novartis Ag |
Kombinacije, ki obsegajo antidiaroično sredstvo in epotilon ali epotilonski derivat
|
|
US6756063B2
(en)
*
|
2001-03-29 |
2004-06-29 |
Zoltan Laboratories, Llc |
Methods and compositions for the treatment of human and animal cancers
|
|
US7053072B2
(en)
|
2001-05-11 |
2006-05-30 |
Medimmune Oncology, Inc. |
Methods for the administration of amifostine and related compounds
|
|
US20030045515A1
(en)
*
|
2001-05-24 |
2003-03-06 |
Lise Binderup |
Combination medicament for treatment of neoplastic diseases
|
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US6476068B1
(en)
|
2001-12-06 |
2002-11-05 |
Pharmacia Italia, S.P.A. |
Platinum derivative pharmaceutical formulations
|
|
US6596320B1
(en)
*
|
2002-01-11 |
2003-07-22 |
Bionumerik Pharmaceuticals, Inc. |
Method for treating cancer having greater efficacy and reduced adverse effects
|
|
US6816571B2
(en)
*
|
2002-02-06 |
2004-11-09 |
L-3 Communications Security And Detection Systems Corporation Delaware |
Method and apparatus for transmitting information about a target object between a prescanner and a CT scanner
|
|
US20030223991A1
(en)
|
2002-03-15 |
2003-12-04 |
Cherwinski Holly M. |
Methods of modulating CD200 receptors
|
|
US8710095B2
(en)
*
|
2002-04-30 |
2014-04-29 |
Bionumerik Pharmaceuticals, Inc. |
Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
|
|
PL372761A1
(en)
*
|
2002-05-17 |
2005-08-08 |
Leo Pharma A/S |
Cyanoguanidine prodrugs
|
|
EP1507760B1
(en)
*
|
2002-05-17 |
2007-08-01 |
Leo Pharma A/S |
Cyanoguanidine prodrugs
|
|
US7253193B2
(en)
*
|
2002-05-17 |
2007-08-07 |
Leo Pharma A/S |
Cyanoguanidine prodrugs
|
|
US20040038904A1
(en)
*
|
2002-05-21 |
2004-02-26 |
Angela Ogden |
Method of treating multiple sclerosis
|
|
AU2003243351B2
(en)
|
2002-05-31 |
2009-04-30 |
Pharmagenesis, Inc. |
Triptolide derivatives for modulation of apoptosis and immunosuppression
|
|
WO2004012746A2
(en)
*
|
2002-08-02 |
2004-02-12 |
The Regents Of The University Of California |
New uses for inhibitors of inosine monophosphate dehydrogenase
|
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
|
WO2004035032A2
(en)
*
|
2002-08-20 |
2004-04-29 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
|
AU2003276689B2
(en)
*
|
2002-09-05 |
2009-04-09 |
Bharat Serums And Vaccines Ltd. |
Liquid stable composition of oxazaphosphorine with mesna
|
|
US7025745B2
(en)
*
|
2002-10-07 |
2006-04-11 |
Advanced Cardiovascular Systems, Inc. |
Method of making a catheter balloon using a tapered mandrel
|
|
WO2004054569A1
(en)
*
|
2002-12-16 |
2004-07-01 |
Council Of Scientific And Industrial Research |
Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings
|
|
US20040203034A1
(en)
*
|
2003-01-03 |
2004-10-14 |
The University Of Chicago |
Optimization of cancer treatment with irinotecan
|
|
BRPI0407096A
(pt)
*
|
2003-02-03 |
2006-01-24 |
Neopharm Inc |
Taxano encapsulado em lipossomo estável, estéril e filtrável e outros fármacos antineoplásicos
|
|
ATE397091T1
(de)
*
|
2003-05-30 |
2008-06-15 |
Univ Chicago |
Verfahren und zusammensetzungen zur vorhersage der irinotecantoxizität
|
|
US20040266808A1
(en)
*
|
2003-06-27 |
2004-12-30 |
Kamen Barton A. |
Treatment of antifolate neurotoxicity
|
|
SI2263694T1
(sl)
*
|
2003-09-25 |
2013-09-30 |
Astellas Pharma Inc. |
Antitumorsko sredstvo, ki obsega inhibitor histon-deacetilaze FK228 in inhibitor topoizomeraze II doksorubicin
|
|
US7820834B2
(en)
*
|
2003-12-24 |
2010-10-26 |
Pharmagenesis, Inc. |
Triptolide 5,6-derivatives as immunomodulators and anticancer agents
|
|
WO2005077008A2
(en)
*
|
2004-02-09 |
2005-08-25 |
Pharmagenesis, Inc. |
Methods for isolation of triptolide compounds from tripterygium wilfordii
|
|
US20050187288A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Chiang Li |
Beta-lapachone and methods of treating cancer
|
|
US20050192247A1
(en)
*
|
2004-02-23 |
2005-09-01 |
Li Chiang J. |
Method of treating cancers
|
|
JP5057966B2
(ja)
*
|
2004-03-02 |
2012-10-24 |
ファーマジェネシス, インコーポレイテッド |
免疫調節剤および抗癌剤としてのトリプトライドラクトン環誘導体
|
|
US20090247475A1
(en)
*
|
2004-03-05 |
2009-10-01 |
The Regents Of The University Of California |
Methods and compositions relating to pharmacogenetics of different gene variants in the context of irinotecan-based therapies
|
|
US7200207B2
(en)
*
|
2004-03-13 |
2007-04-03 |
Intrado Inc. |
Communication network for providing emergency services
|
|
EP1804816B1
(en)
*
|
2004-03-26 |
2011-12-21 |
Vion Pharmaceuticals, Inc. |
Combination therapy comprising cloretazine(tm)
|
|
US20050256055A1
(en)
*
|
2004-05-12 |
2005-11-17 |
Hausheer Frederick H |
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents
|
|
US20090111735A1
(en)
*
|
2004-05-12 |
2009-04-30 |
Bionumerik Pharmaceuticals, Inc. |
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents
|
|
JP4433918B2
(ja)
*
|
2004-07-15 |
2010-03-17 |
コニカミノルタエムジー株式会社 |
画像形成方法
|
|
JP4927735B2
(ja)
|
2004-08-20 |
2012-05-09 |
ユニバーシテイ・オブ・バージニア・パテント・フアウンデーシヨン |
T型カルシウムチャネル阻害剤
|
|
US20060063742A1
(en)
*
|
2004-09-21 |
2006-03-23 |
Hausheer Frederick H |
Method of treatment for or protection against lymphedema
|
|
TWI366459B
(en)
*
|
2004-09-28 |
2012-06-21 |
Ind Tech Res Inst |
Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
|
|
WO2006044496A2
(en)
*
|
2004-10-13 |
2006-04-27 |
Pharmagenesis, Inc. |
Identification and screening of triptolide target molecules
|
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
|
WO2006066584A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Leo Pharma A/S |
Novel cyanoguanidine compounds
|
|
EP1790343A1
(en)
*
|
2005-11-11 |
2007-05-30 |
Emotional Brain B.V. |
Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
|
|
US8143236B2
(en)
*
|
2005-12-13 |
2012-03-27 |
Bionumerik Pharmaceuticals, Inc. |
Chemoprotective methods
|
|
AU2006326442B2
(en)
*
|
2005-12-13 |
2012-03-01 |
Bionumerik Pharmaceuticals, Inc. |
Chemoprotective methods and compositions
|
|
US8895531B2
(en)
*
|
2006-03-23 |
2014-11-25 |
Rfs Pharma Llc |
2′-fluoronucleoside phosphonates as antiviral agents
|
|
US8168661B2
(en)
*
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8178564B2
(en)
|
2006-11-06 |
2012-05-15 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8168662B1
(en)
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US20110033528A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Poniard Pharmaceuticals, Inc. |
Stabilized picoplatin oral dosage form
|
|
KR20090109130A
(ko)
*
|
2007-02-09 |
2009-10-19 |
포니아드 파마슈티칼즈, 인크. |
캡슐화된 피코플라틴
|
|
US8372834B2
(en)
*
|
2007-03-02 |
2013-02-12 |
University Of Wollongong |
Compositions and methods for delivery of anti-cancer agents
|
|
US20100260832A1
(en)
*
|
2007-06-27 |
2010-10-14 |
Poniard Pharmaceuticals, Inc. |
Combination therapy for ovarian cancer
|
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
|
US20100310661A1
(en)
*
|
2007-07-16 |
2010-12-09 |
Poniard Pharmaceuticals, Inc. |
Oral formulations for picoplatin
|
|
WO2009072004A2
(en)
*
|
2007-09-26 |
2009-06-11 |
Gemin X Pharmaceuticals Canada, Inc. |
Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor
|
|
US8586636B2
(en)
|
2007-11-20 |
2013-11-19 |
Lankenau Institute For Medical Research |
Disulfide chemotherapeutic agents and methods of use thereof
|
|
EP2249827A4
(en)
*
|
2008-02-08 |
2012-05-30 |
Poniard Pharmaceuticals Inc |
USE OF PICOPLATIN AND CETUXIMAB IN THE TREATMENT OF COLORECTAL CANCER
|
|
CN102014919B
(zh)
|
2008-03-03 |
2015-02-25 |
托斯克公司 |
减少毒性的甲氨蝶呤佐剂及其使用方法
|
|
CA2753844A1
(en)
*
|
2008-03-05 |
2009-09-11 |
Vicus Therapeutics, Llc |
Compositions and methods for mucositis and oncology therapies
|
|
EP2252246B1
(en)
*
|
2008-03-14 |
2014-06-18 |
Bionumerik Pharmaceuticals, Inc. |
Chemoprotective methods and compositions
|
|
CA2718233A1
(en)
*
|
2008-03-14 |
2009-09-17 |
Bionumerik Pharmaceuticals, Inc. |
Compositions and methods of use of compounds to increase cancer patient survival time
|
|
EP2249825B1
(en)
*
|
2008-03-14 |
2015-10-07 |
Bionumerik Pharmaceuticals, Inc. |
Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
|
|
US9320760B2
(en)
*
|
2008-03-14 |
2016-04-26 |
Bionumerik Pharmaceuticals, Inc. |
Compositions and methods of use of compounds to increase cancer patient survival time
|
|
EP2430178B1
(en)
|
2009-05-15 |
2014-07-09 |
Lankenau Institute for Medical Research |
Methods and kits for measuring toxicity and oxidative stress in live cells
|
|
ES2557407T3
(es)
|
2010-03-01 |
2016-01-25 |
Tau Therapeutics Llc |
Procedimiento de imaginología de una enfermedad
|
|
EP2590938B1
(en)
|
2010-07-09 |
2017-06-07 |
Welichem Biotech Inc. |
Novel sulfonamide compounds for inhibition of metastatic tumor growth
|
|
US9271952B2
(en)
*
|
2011-10-11 |
2016-03-01 |
Complexa, Inc. |
Compositions and methods for treating nephropathy
|
|
CN102871991B
(zh)
*
|
2012-10-24 |
2014-06-18 |
中国医学科学院放射医学研究所 |
二甲双胍在对放化疗损伤起保护作用的药物中的应用
|
|
CA2919837A1
(en)
*
|
2013-08-02 |
2015-02-05 |
Children's Hospital Medical Center |
Compositions and methods for treating disease states associated with activated t cells and/or b cells
|
|
US9470029B2
(en)
|
2014-05-30 |
2016-10-18 |
Pella Corporation |
Casement pivot arm roller hinge
|
|
LT3865484T
(lt)
|
2015-07-07 |
2024-02-12 |
H. Lundbeck A/S |
Pde9 inhibitorius su imidazopirazinono karkasu, skirtas periferinių ligų gydymui
|
|
IL297844A
(en)
|
2015-10-02 |
2023-01-01 |
Complexa Inc |
Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids
|
|
HRP20240363T1
(hr)
|
2018-05-25 |
2024-06-07 |
Cardurion Pharmaceuticals, Inc. |
Monohidratni i kristalni oblici 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirolidin-3-il]-3-tetrahidropiran-4-il-7h-imidazo [1,5-a] pirazin-8-ona
|
|
WO2020047311A1
(en)
|
2018-08-31 |
2020-03-05 |
Imara Inc. |
Pde9 inhibitors for treating sickle cell disease
|